WELL HEALTH TECHNOLOGIES COR (WELL.CA) Fundamental Analysis & Valuation

TSX:WELL • CA94947L1022

Current stock price

3.8 CAD
-0.06 (-1.55%)
Last:

This WELL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. WELL.CA Profitability Analysis

1.1 Basic Checks

  • WELL had negative earnings in the past year.
  • In the past year WELL has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: WELL reported negative net income in multiple years.
  • WELL had a positive operating cash flow in 4 of the past 5 years.
WELL.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • WELL has a Return On Assets of -2.14%. This is comparable to the rest of the industry: WELL outperforms 46.15% of its industry peers.
  • WELL's Return On Equity of -5.12% is in line compared to the rest of the industry. WELL outperforms 46.15% of its industry peers.
Industry RankSector Rank
ROA -2.14%
ROE -5.12%
ROIC N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
WELL.CA Yearly ROA, ROE, ROICWELL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • The Gross Margin of WELL (39.97%) is better than 69.23% of its industry peers.
  • WELL's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WELL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
WELL.CA Yearly Profit, Operating, Gross MarginsWELL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. WELL.CA Health Analysis

2.1 Basic Checks

  • WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, WELL has more shares outstanding
  • The number of shares outstanding for WELL has been increased compared to 5 years ago.
  • Compared to 1 year ago, WELL has an improved debt to assets ratio.
WELL.CA Yearly Shares OutstandingWELL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
WELL.CA Yearly Total Debt VS Total AssetsWELL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • WELL has an Altman-Z score of 1.05. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
  • WELL has a Altman-Z score of 1.05. This is comparable to the rest of the industry: WELL outperforms 53.85% of its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that WELL is somewhat dependend on debt financing.
  • The Debt to Equity ratio of WELL (0.67) is better than 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACCN/A
WACC7.85%
WELL.CA Yearly LT Debt VS Equity VS FCFWELL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • WELL has a Current Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 0.92, WELL is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • WELL has a Quick Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • WELL has a better Quick ratio (0.92) than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
WELL.CA Yearly Current Assets VS Current LiabilitesWELL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. WELL.CA Growth Analysis

3.1 Past

  • WELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
  • Looking at the last year, WELL shows a very strong growth in Revenue. The Revenue has grown by 26.20%.
  • The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%

3.2 Future

  • WELL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.72% yearly.
  • WELL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.80% yearly.
EPS Next Y179.65%
EPS Next 2Y67.99%
EPS Next 3Y40.74%
EPS Next 5Y19.72%
Revenue Next Year41.58%
Revenue Next 2Y25.63%
Revenue Next 3Y19.16%
Revenue Next 5Y15.8%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
WELL.CA Yearly Revenue VS EstimatesWELL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL.CA Yearly EPS VS EstimatesWELL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

5

4. WELL.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • WELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 8.98, the valuation of WELL can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, WELL is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, WELL is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.98
WELL.CA Price Earnings VS Forward Price EarningsWELL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • WELL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. WELL is cheaper than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.65
WELL.CA Per share dataWELL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as WELL's earnings are expected to grow with 40.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.99%
EPS Next 3Y40.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WELL.CA Dividend Analysis

5.1 Amount

  • No dividends for WELL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WELL.CA Fundamentals: All Metrics, Ratios and Statistics

WELL HEALTH TECHNOLOGIES COR

TSX:WELL (3/26/2026, 7:00:00 PM)

3.8

-0.06 (-1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-19
Earnings (Next)05-12
Inst Owners3.73%
Inst Owner ChangeN/A
Ins Owners22.62%
Ins Owner ChangeN/A
Market Cap970.94M
Revenue(TTM)1.21B
Net Income(TTM)-43.25M
Analysts82.11
Price Target7.78 (104.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.08%
Min EPS beat(2)-41.18%
Max EPS beat(2)-32.99%
EPS beat(4)0
Avg EPS beat(4)-244.03%
Min EPS beat(4)-696.08%
Max EPS beat(4)-32.99%
EPS beat(8)2
Avg EPS beat(8)1902.08%
EPS beat(12)3
Avg EPS beat(12)1068.91%
EPS beat(16)3
Avg EPS beat(16)736.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-1.25%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)3
Avg Revenue beat(8)-1.47%
Revenue beat(12)5
Avg Revenue beat(12)-0.69%
Revenue beat(16)9
Avg Revenue beat(16)0.18%
PT rev (1m)1.54%
PT rev (3m)-0.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)32.66%
EPS NY rev (3m)32.66%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.98
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB N/A
EV/EBITDA 16.65
EPS(TTM)-0.12
EYN/A
EPS(NY)0.42
Fwd EY11.14%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.73
BVpS3.3
TBVpS-2.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.14%
ROE -5.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.97%
FCFM N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score1
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 6.23
Cap/Depr 27.43%
Cap/Sales 2.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 1.05
F-Score1
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y179.65%
EPS Next 2Y67.99%
EPS Next 3Y40.74%
EPS Next 5Y19.72%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
Revenue Next Year41.58%
Revenue Next 2Y25.63%
Revenue Next 3Y19.16%
Revenue Next 5Y15.8%
EBIT growth 1Y-102.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.48%
EBIT Next 3Y65.66%
EBIT Next 5Y47.63%
FCF growth 1Y-170.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-132.25%
OCF growth 3Y-22.85%
OCF growth 5YN/A

WELL HEALTH TECHNOLOGIES COR / WELL.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to WELL.CA.


Can you provide the valuation status for WELL HEALTH TECHNOLOGIES COR?

ChartMill assigns a valuation rating of 5 / 10 to WELL HEALTH TECHNOLOGIES COR (WELL.CA). This can be considered as Fairly Valued.


What is the profitability of WELL stock?

WELL HEALTH TECHNOLOGIES COR (WELL.CA) has a profitability rating of 2 / 10.